Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | NPX267 |
Trade Name | |
Synonyms | NPX-267|NPX 267 |
Drug Descriptions |
NPX267 is a monoclonal antibody targeting KIR3DL3, which potentially blocks HHLA2 binding and leads to enhanced antitumor immune response (J Immunother Cancer 2022;10:doi: 10.1136/jitc-2022-SITC2022.0489). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C20114 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
NPX267 | NPX267 | 0 | 1 |